Company intelligence / Profile preview

SensCure Biotechnology

Ningbo, Zhejiang, 中国 (China)senscure.net ↗

Ownership: Private
Employees: ~7
Development stage: Commercial

Overview

SensCure has developed several innovative medical devices for minimally invasive endoscopic surgery. Their single-use cryoablation catheter for bladder tumors has entered special examination procedures for innovative medical devices in China. Other products such as the laparoscopic single port multi-channel access platform and pulmonary nodule localization needle have received regulatory approval from the NMPA. Clinical trials are ongoing or recently initiated for several pipeline products

Therapeutic areas: OncologyPulmonology
Modalities: DeviceCryotherapy deviceSurgical instrument
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on SensCure Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SensCure Biotechnology.

Explore the full profile